To further confirm the significance of the two factors in the diagnosis and therapy of NSCLC, our group is now working on an easy-test of Sox2 and Oct4 and a quick knocking down of the two transcription factors. This evidence concerns the gene POU5F1 and non-small cell lung carcinoma.